SLFN11 biomarker status predicts response to lurbinectedin as a single agent and in combination with ATR inhibition in small cell lung cancer
暂无分享,去创建一个
Jing Wang | L. Byers | C. Gay | K. Cargill | Li Shen | R. Cardnell | Bingnan Zhang | C. Stewart | K. Ramkumar | K. Kundu | C. A. Stewart